Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression: a Phase 2a Pilot Randomized Clinical Trial (COGUNILA)

Phase: PHASE1, PHASE2 | Sponsor: Federal University of Latin American Integration | Compound: Psychedelic

Status

recruiting

Institution

Federal University of Latin American Integration

Start date

2024-09-05

End date

2026-11-20

Registry ID

NCT06898606

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.